BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18607543)

  • 1. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma.
    Pierson J; Hostager B; Fan R; Vibhakar R
    J Neurooncol; 2008 Oct; 90(1):1-7. PubMed ID: 18607543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6.
    Chen SM; Chen HC; Chen SJ; Huang CY; Chen PY; Wu TW; Feng LY; Tsai HC; Lui TN; Hsueh C; Wei KC
    World J Surg Oncol; 2013 Apr; 11():87. PubMed ID: 23594394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Circular RNA circSKA3 Facilitates the Malignant Biological Behaviors of Medulloblastoma via miR-520 h/CDK6 Pathway.
    Liu XC; Wang FC; Wang JH; Zhao JY; Ye SY
    Mol Biotechnol; 2022 Sep; 64(9):1022-1033. PubMed ID: 35352283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma.
    Venkataraman S; Birks DK; Balakrishnan I; Alimova I; Harris PS; Patel PR; Handler MH; Dubuc A; Taylor MD; Foreman NK; Vibhakar R
    J Biol Chem; 2013 Jan; 288(3):1918-28. PubMed ID: 23212916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of lncRNA-UCA1 inhibits cell viability and migration of human glioma cells by miR-193a-mediated downregulation of CDK6.
    Xin H; Liu N; Xu X; Zhang J; Li Y; Ma Y; Li G; Liang J
    J Cell Biochem; 2019 Sep; 120(9):15157-15169. PubMed ID: 31111564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3).
    Kanchan RK; Perumal N; Atri P; Chirravuri Venkata R; Thapa I; Klinkebiel DL; Donson AM; Perry D; Punsoni M; Talmon GA; Coulter DW; Boue' DR; Snuderl M; Nasser MW; Batra SK; Vibhakar R; Mahapatra S
    Brain Pathol; 2020 Jul; 30(4):732-745. PubMed ID: 32145124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of miR-124 inhibits growth of medulloblastoma cells.
    Silber J; Hashizume R; Felix T; Hariono S; Yu M; Berger MS; Huse JT; VandenBerg SR; James CD; Hodgson JG; Gupta N
    Neuro Oncol; 2013 Jan; 15(1):83-90. PubMed ID: 23172372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
    Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
    Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of CDK6 expression by microRNA-126-5p and its influence on the proliferation and invasion of esophageal cancer cells.
    Gu JF; Liu SG; Pan Q; Qin F; Li YY
    Anat Rec (Hoboken); 2020 Nov; 303(11):2811-2820. PubMed ID: 31916689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells.
    Feng L; Xie Y; Zhang H; Wu Y
    Med Oncol; 2012 Jun; 29(2):856-63. PubMed ID: 21264532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138.
    Zhang H; Li H; Liu Z; Ge A; Guo E; Liu S; Chen Z
    J Cell Biochem; 2018 Dec; 119(12):9866-9877. PubMed ID: 30156009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-29c suppresses cell invasion and migration by directly targeting CDK6 in gastric carcinoma.
    Jiang H; Liu ZN; Cheng XH; Zhang YF; Dai X; Bao GM; Zhou LB
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7920-7928. PubMed ID: 31599417
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Pan H; Hong Y; Yu B; Li L; Zhang X
    Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301
    [No Abstract]   [Full Text] [Related]  

  • 14. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
    Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
    Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
    Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
    J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1.
    Kouhkan F; Mobarra N; Soufi-Zomorrod M; Keramati F; Hosseini Rad SM; Fathi-Roudsari M; Tavakoli R; Hajarizadeh A; Ziaei S; Lahmi R; Hanif H; Soleimani M
    J Med Genet; 2016 Jan; 53(1):24-33. PubMed ID: 26510428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [miRNA-191-5p represses cell growth by targeting CDK6 in gastric cancer].
    Cao NJ; Hou HH; Li F; Guo ST; Wang Y
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(46):3689-3693. PubMed ID: 33342146
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells.
    Whiteway SL; Harris PS; Venkataraman S; Alimova I; Birks DK; Donson AM; Foreman NK; Vibhakar R
    J Neurooncol; 2013 Jan; 111(2):113-21. PubMed ID: 23138228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
    Xu YY; Song YQ; Huang ZM; Zhang HB; Chen M
    Kaohsiung J Med Sci; 2019 May; 35(5):277-283. PubMed ID: 30897301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
    Kikkawa N; Kinoshita T; Nohata N; Hanazawa T; Yamamoto N; Fukumoto I; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Oncol; 2014 Jun; 44(6):2085-92. PubMed ID: 24647829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.